Faculty of Law, University of Macau 59193 Macau China.
Eur J Health Law. 2021 Apr 19;28(2):165-183. doi: 10.1163/15718093-BJA10042.
This paper focuses on the COVID-19 vaccines authorised for use in the European Union, and explores the mechanisms in place to control vaccine safety and to compensate injured patients, mainly in the context of European law. Based on these considerations, the paper concludes that the refusal by some potential vaccinees to take the vaccine based on safety concerns is ungrounded and an indication of unrealistic expectations, but that in order to build public trust proper compensation mechanisms should be in place.
本文重点关注在欧盟获得使用授权的 COVID-19 疫苗,并探讨了控制疫苗安全性和赔偿受伤害患者的机制,主要是在欧洲法律的背景下。基于这些考虑,本文得出结论,一些潜在疫苗接种者因安全问题拒绝接种疫苗是没有根据的,也是不切实际的期望的表现,但为了建立公众信任,应建立适当的赔偿机制。